Abridge Inc
PrivateLast Round
Series E
Jun 24, 2025
Est. Valuation
$5.3B
Total Funding Raised
$747.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Abridge Inc is a healthcare technology company that provides an AI-powered platform for clinical documentation by transcribing and summarizing patient-clinician conversations.
Sector
Healthcare & Life Sciences
Verticals
NLP & Conversational AI, EHR & EMR, Medical AI, Clinical Trials, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Price History
Caplight MarketPrice™ estimate for Abridge Inc, published with a 90-day delay.
Caplight MarketPrice™
$210.07
per share, as of April 2026
-11.6%
6-month change
Caplight MarketPrice™ is an estimate of private secondary market pricing, shown here on a delayed basis for illustrative purposes only. It may be incomplete, is subject to change, and may not be relied upon for any purpose or considered investment advice.
Abridge Inc Comparables
Compare Abridge Inc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Commure | 90% | |
| Suki | 88% | |
| Ambience Healthcare | 88% | |
Abridge Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jun 24, 2025 | ||||
| Series D | Feb 17, 2025 | ||||
| Series C | Feb 23, 2024 | ||||
| Series B | Oct 26, 2023 | ||||
| Series A Extension | Aug 11, 2022 | ||||
Seed | Oct 6, 2020 |
Secondary Market Activity
Bids, offers, and trades by month
| Operation | Date | Price | Size | Share Class | Structure |
|---|---|---|---|---|---|
OFFER |
Key People
Founding team and executive leadership
Abridge Inc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series E |
| SV Angel | Series D |
| California Health Care Foundation | Series D |
| Aetna Ventures | Series B |
| Union Square Ventures | Series C, Series A Extension, Series B, Seed |
| Kaiser Permanente Ventures | Series B, Series C |
| Khosla Ventures | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Grew 20% QoQ, from 532 to 637 employees.
- Apr 21, 2026
HonorHealth selected ambient AI solution for 500 clinicians.
Abridge Inc Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Abridge Inc's valuation, stock price, and market status.